Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Buelow

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Transplantation Proceedings|March 27, 2001
Induction of heme-oxygenase-1 prevents ischemia/reperfusion injury and improves long-term graft outcome in rat renal allograftsS G Tullius, M Nieminen-Kelhä, U Bachmann, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 14, 2006
Improved long-term graft survival after HO-1 induction in brain-dead donorsK Kotsch, M Francuski, A Pascher, et al.
Clinical and Translational Science|September 9, 2020
DNA Methylation-Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid LeukemiaDaelynn R Buelow, Jason T Anderson, Stanley B Pounds, et al.
Transplantation|July 27, 1996
Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejectionR H Kerman, B Susskind, R Buelow, et al.
Blood Advances|July 7, 2022
BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factorsDaelynn R Buelow, Bhavana Bhatnagar, Shelley J Orwick, et al.
Cancer Research Communications|August 22, 2025
Drug-drug interaction liabilities with BTK inhibitor TL-895Jack C Stromatt, Eman A Ahmed, Thomas Drabison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2022
Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem DuplicationHiroto Inaba, Jolieke G van Oosterwijk, John C Panetta, et al.
Cancer Research Communications|March 2, 2026
Mechanisms Underlying Cedazuridine-Mediated Enhancement of Oral Decitabine BioavailabilityNadeen Anabtawi, Thomas Drabison, Alexander F Ham, et al.
Leukemia & Lymphoma|June 2, 2016
Transcriptome profiling of patient derived xenograft models established from pediatric acute myeloid leukemia patients confirm maintenance of FLT3-ITD mutationChristina D Drenberg, Daelynn R Buelow, Stanley B Pounds, et al.
Cancers|January 8, 2023
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with <i>TP53</i> Mutation/DeletionEric D Eisenmann, Jack C Stromatt, Sydney Fobare, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Transplantation Proceedings|March 27, 2001
Induction of heme-oxygenase-1 prevents ischemia/reperfusion injury and improves long-term graft outcome in rat renal allograftsS G Tullius, M Nieminen-Kelhä, U Bachmann, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 14, 2006
Improved long-term graft survival after HO-1 induction in brain-dead donorsK Kotsch, M Francuski, A Pascher, et al.
Clinical and Translational Science|September 9, 2020
DNA Methylation-Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid LeukemiaDaelynn R Buelow, Jason T Anderson, Stanley B Pounds, et al.
Transplantation|July 27, 1996
Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejectionR H Kerman, B Susskind, R Buelow, et al.
Blood Advances|July 7, 2022
BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factorsDaelynn R Buelow, Bhavana Bhatnagar, Shelley J Orwick, et al.
Cancer Research Communications|August 22, 2025
Drug-drug interaction liabilities with BTK inhibitor TL-895Jack C Stromatt, Eman A Ahmed, Thomas Drabison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2022
Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem DuplicationHiroto Inaba, Jolieke G van Oosterwijk, John C Panetta, et al.
Cancer Research Communications|March 2, 2026
Mechanisms Underlying Cedazuridine-Mediated Enhancement of Oral Decitabine BioavailabilityNadeen Anabtawi, Thomas Drabison, Alexander F Ham, et al.
Leukemia & Lymphoma|June 2, 2016
Transcriptome profiling of patient derived xenograft models established from pediatric acute myeloid leukemia patients confirm maintenance of FLT3-ITD mutationChristina D Drenberg, Daelynn R Buelow, Stanley B Pounds, et al.
Cancers|January 8, 2023
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with <i>TP53</i> Mutation/DeletionEric D Eisenmann, Jack C Stromatt, Sydney Fobare, et al.
Pageof 12